CDKN1B and myelodysplastic syndrome: As shown in Figure 4C, the expression of CDKN1A and CDKN1B was scarce in untreated MDS-L cells, but after DAC treatment, the expression of CDKN1A and CDKN1B was upregulated with drug maintenance application.